

Awarded 43 CME points by Dubai Health Authority for EIOC 2022.
Delegates with full attendance from 21 – 23 October, 2022 can avail up to 21 CME points
In conjunction with


In collaboration with


About Event
Excellence in Oncology Care
The landscape for Oncology Care is changing at a rapid pace. With EIOC we envision this platform be a meeting ground for global and regional experts to meet for better learnings and take away valuable experiences to their workplace. EIOC which stands for Excellence in Oncology Care is a platform for not just one cancer specialty but a holistic approach to 14 sub therapies within Oncology.
When
6 – 8 October, 2023
- 00Days
- 00Hours
- 00Minutes
- 00Seconds

- Detailed interactive event agenda
- Personal custom agenda for specific attendees
- Attendees can save specific sessions to their personal agenda
- Live stream conference sessions, networking and interaction
- Questions can be asked live from anywhere
- Easily cycle between sessions, video, comments and Q&A

- Includes a filterable, tiered directory of sponsors/exhibitors
- Dedicated profile for each company including information, downloads, products and video
- Interact with assigned representatives immediately
- Virtual industry sponsored satellite symposia

- Instant Messaging available between onsite and offsite participants
- Ability to filter between onsite and offsite participants
- Network and set up virtual face to face meetings with other users
- Participants can connect via video call to the members of your team

- Connect with onsite and offsite participants
- Offsite participants provided with a virtual meeting automatically
- In-App live video calling
- Auto notification when the virtual meeting begins
- Make notes and download post meeting
Photo Gallery
Photo Gallery
2022 CME Partner

2022 Supported By








2022 Main Sponsors


2022 Platinum Sponsors



2022 Partners & Sponsors
2022 Main Sponsors


2022 Platinum Sponsors



2022 Gold Sponsors




2022 Healthcare Partner

2022 Healthcare Partner

2022 Gold Sponsors





2022 Silver Sponsors








2022 Support Sponsors





2022 Exhibitors




2022 Supported by






2022 Media Partners






Hot of the press ! First oral seed to be approved!!! Restricted to esr1 mutation pos disease.
What are your thoughts?
Hot of the press ! Was this something you expected? Thoughts?
ASCO rapid communication that incorporates data from tropics 02 to allow use of sacituzumab govitecan in pts with hr pos mbc who have progressed on endocrine therapy and have recieved at least two lines of chemotherapy.
#ASCO #CANCERRESEARCH